Signals, Powered By EquityPandit
On Thursday, the drug major, Aurobindo Pharma said that the USFDA has given its final approval to the company for the manufacture and market Memantine Hydrochloride tablets that are used in the treatment of Alzheimer’s.
Aurobindo Pharma said in a BSE filing that “The company has received the final approval from the US Food & Drug Administration (US FDA) to manufacture and market Memantine Hydrochloride Tablets, 5mg and 10mg (ANDA 203175).”
“This approval is an extension of tentative approval received on March 24, 2014. The product is ready for launch,” it added.
